InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
67,309.84
(
0.20%
)
Post# of 25232
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

Profit_Ace

Send PM Follow Ignore
Followers 6
Posts 212
Boards Moderated 0
Alias Born 10/22/2003

Profit_Ace

Re: None

Thursday, 11/25/2004 3:16:16 AM

Thursday, November 25, 2004 3:16:16 AM

Post# of 25232
OSIP: Now I understand why the otm Dec. calls held their value despite a declining stock. Traders are buying a straddle in OSIP ahead of the release of survival data for Iressa, the competing drug to OSIP's Tarceva. AZN is expected to release the findings by year end which is approaching fast. Linlee and Checkers: I hope you read this. I have the calls and now will look to hedge with puts.

http://www.investorshub.com/boards/read_msg.asp?message_id=4651660
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up